ワルファリン誘発性下舌および喉血腫の男性における呼吸道阻害

Mohamed Darwish¹, Fathiya Al Nagbi¹, Hamed Aljanaahi¹

¹Department of Emergency Medicine, Tawam Hospital, Al Ain, Abu Dhabi, UAE.

BMJ case reports

|August 28, 2025

まとめ

ワルファリン治療は希少な呼吸道血腫を引き起こし阻害を引き起こす可能性があります治療上の国際正常化比率の患者で下血腫の治療に成功しました

科学分野:

医学について
血液学
耳鼻喉科

背景:

ウォルファリン療法では,胃腸,尿器,頭蓋内出血がよく起こります.
呼吸道血腫はワーファリンの珍しいが深刻な合併症であり,特に超治療的な国際正常化比率 (INR) で発生する.
消化不全,唾液漏れ,音不全,話すことができないなどの症状は,呼吸道が関与している可能性を示唆しています.

研究の目的:

ワーファリンを投与した患者で呼吸道阻害を引き起こした下血腫の症例を報告する.
呼吸道 hematomasの診断と管理戦略について議論します.
呼吸道緊急事態の管理に多学科チームによる関与の重要性を強調する.

主な方法:

50代前半の男性で喉下血腫の症例報告です
難易度の高い呼吸道管理に関する現在のガイドラインのレビュー
保守的対決定的な呼吸道管理オプションの議論

主要な成果:

患者の症状は呼吸道障害を示唆しています
緊急呼吸器切開手術が成功しました
血腫は治され患者の呼吸道が回復しました

結論:

呼吸道血腫は稀ですがウォルファリン治療の重大な合併症で迅速な診断が必要です
早期の疑惑と介入は患者の生存に不可欠です
緊急の呼吸道阻害の効果的な管理には多学科的なアプローチが不可欠です.

キーワード:

耳鼻喉ワルファリン療法

さらに関連する動画

28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K

07:31

Image Acquisition using Portable Sonography for Emergency Airway Management

Published on: September 28, 2022

2.5K

関連する概念動画

01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.3K

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

1.3K

01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

889

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

889

01:24

Disorders of Hemostasis

1.2K

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

1.2K

01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

01:26

Tonsillitis II: Management

174

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.

174

関連する実験動画